Skip to main content
Log in

Understanding the Aftermath of Brexit: Implications for the Pharmaceutical Industry

  • Commentary
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Science Media Center. Expert reaction to the UK voting to leave the European Union. 2016. http://www.sciencemediacentre.org/expert-reaction-to-the-uk-voting-to-leave-the-european-union/. Accessed 27 June 2016.

  2. Office for National Statistics. Statistical bulletin: Business Enterprise Research and Development: 2014. 2015. http://www.ons.gov.uk/economy/governmentpublicsectorandtaxes/researchanddevelopmentexpenditure/bulletins/businessenterpriseresearchanddevelopment/2014#rd-expenditure. Accessed 27 June 2016.

  3. European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures—Edition 2015. 2015. http://www.efpia.eu/uploads/Figures_2015_Key_data.pdf. Accessed 27 June 2016.

  4. Association of the British Pharmaceutical Industry. “EU membership enables the UK to push the boundaries of scientific progress”, says ABPI. 2016. http://www.abpi.org.uk/media-centre/newsreleases/2016/Pages/EU-membership-enables-the-UK-to-push-the-boundaries-of-scientific-progress-says-ABPI.aspx. Accessed 27 June 2016.

  5. Innovative Medicines Initiative. The IMI funding model. 2010. https://www.imi.europa.eu/content/imi-funding-model. Accessed 27 June 2016.

  6. Van Noorden R. Brexit watch: UK researchers scramble to save science. Nature News. 2016. http://www.nature.com/news/brexit-watch-uk-researchers-scramble-to-save-science-1.20307. Accessed 04 Aug 2016.

  7. Cressey D. Academics across Europe join ‘Brexit’ debate. Nature. 2016;530(7588):15.

    Article  CAS  PubMed  Google Scholar 

  8. Univerisites UK. Economic impact on the UK of EU research funding to UK universities. 2016. http://www.universitiesuk.ac.uk/policy-and-analysis/reports/Pages/economic-impact-on-the-uk-of-eu-research-funding-to-uk-universities.aspx. Accessed 04 Aug 2016.

  9. Staines R. UK could quit EU drug regulation system—minister. 2016. http://pharmaphorum.com/news/uk-leave-drugs-regulation-system-minister/. Accessed 04 Aug 2016.

  10. European Patent Office. Legal foundations. 2013. https://www.epo.org/about-us/organisation/foundation.html. Accessed 27 June 2016.

  11. European Parliament. Article 50 TEU: Withdrawal of a Member State from the EU. 2016. http://www.europarl.europa.eu/RegData/etudes/BRIE/2016/577971/EPRS_BRI%282016%29577971_EN.pdf. Accessed 27 June 2016.

  12. Łazowski A. Unilateral withdrawal from the EU: realistic scenario or a folly? J Euro Public Policy. 2016;. doi:10.1080/13501763.2016.1174529.

    Google Scholar 

  13. Weiler JHH. Alternatives to withdrawal from an international organization: the case of the European Economic Community. Isr Law Rev. 1985;20:282–98.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chie Hoon Song.

Ethics declarations

Funding

No funding was provided for the publication of this work.

Conflict of interest

Chie Hoon Song declares that he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, C.H. Understanding the Aftermath of Brexit: Implications for the Pharmaceutical Industry. Pharm Med 30, 253–256 (2016). https://doi.org/10.1007/s40290-016-0158-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40290-016-0158-2

Keywords

Navigation